Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China · Delayed Price · Currency is CNY 27.47
+0.28 (1.03%)
Feb 3, 2026, 3:00 PM CST
SHA:600993 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 571.6 | 528.09 | 443.25 | 478.57 | 464.59 | 419.06 |
Depreciation & Amortization | 73.33 | 73.33 | 80.56 | 78.51 | 68.57 | 35.25 |
Other Amortization | 13.31 | 13.31 | 9.52 | 9.83 | 9.22 | 20.97 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -5.65 | 0.29 | 0.79 | -8.12 |
Asset Writedown & Restructuring Costs | 5.4 | 5.4 | 0.09 | 0.06 | 0.15 | 0.96 |
Loss (Gain) From Sale of Investments | -13.81 | -13.81 | -91.91 | -2.86 | -54.31 | -100.55 |
Provision & Write-off of Bad Debts | 8.27 | 8.27 | 3.93 | 9.93 | 3.06 | 9.52 |
Other Operating Activities | 119.64 | 30.63 | 35.36 | 18.52 | 26.47 | 21.8 |
Change in Accounts Receivable | -193.98 | -193.98 | 148.03 | -356.2 | 231.67 | -290.06 |
Change in Inventory | -8.7 | -8.7 | 55.32 | -26.26 | -46.37 | 14.8 |
Change in Accounts Payable | 61.32 | 61.32 | -75.45 | 137.86 | -105.32 | 151.66 |
Change in Other Net Operating Assets | - | - | -1.12 | -0.77 | -0.32 | 0.4 |
Operating Cash Flow | 630.12 | 497.61 | 604.07 | 341.85 | 597.17 | 282.99 |
Operating Cash Flow Growth | -25.42% | -17.62% | 76.70% | -42.75% | 111.02% | -42.43% |
Capital Expenditures | -84.19 | -203.85 | -248.36 | -75.01 | -65.1 | -45.41 |
Sale of Property, Plant & Equipment | 1.18 | 0.92 | 3.61 | 0.46 | 0.58 | 3.51 |
Cash Acquisitions | - | - | - | - | - | -22.55 |
Divestitures | - | - | -0.56 | - | 4 | 11 |
Investment in Securities | -721.2 | -60.72 | 675.91 | -574.13 | -36.59 | 320.35 |
Other Investing Activities | 0.07 | - | 17.68 | 29.92 | 34.07 | 3.01 |
Investing Cash Flow | -804.15 | -263.65 | 448.27 | -618.76 | -63.05 | 269.9 |
Short-Term Debt Issued | - | - | - | - | 78 | 135 |
Long-Term Debt Issued | - | 44.6 | 58.6 | 488.31 | - | - |
Total Debt Issued | 15 | 44.6 | 58.6 | 488.31 | 78 | 135 |
Short-Term Debt Repaid | - | - | - | - | -123 | -50.14 |
Long-Term Debt Repaid | - | -91.91 | -429.95 | -127.47 | -32.81 | - |
Total Debt Repaid | -174.71 | -91.91 | -429.95 | -127.47 | -155.81 | -50.14 |
Net Debt Issued (Repaid) | -159.71 | -47.31 | -371.35 | 360.84 | -77.81 | 84.86 |
Common Dividends Paid | -274.05 | -177.28 | -162.71 | -165.04 | -124.5 | -115.6 |
Other Financing Activities | -55.74 | -50.74 | -45.1 | -17.62 | 32.66 | 19.03 |
Financing Cash Flow | -489.49 | -275.33 | -579.16 | 178.18 | -169.64 | -11.72 |
Foreign Exchange Rate Adjustments | 0.03 | 0.24 | 0.26 | 1.24 | -0.6 | -0.96 |
Net Cash Flow | -663.49 | -41.13 | 473.43 | -97.49 | 363.88 | 540.21 |
Free Cash Flow | 545.93 | 293.76 | 355.7 | 266.84 | 532.07 | 237.58 |
Free Cash Flow Growth | 0.48% | -17.41% | 33.30% | -49.85% | 123.96% | -46.64% |
Free Cash Flow Margin | 14.47% | 7.88% | 11.34% | 7.55% | 15.72% | 8.51% |
Free Cash Flow Per Share | 1.27 | 0.68 | 0.83 | 0.62 | 1.24 | 0.55 |
Cash Income Tax Paid | 303 | 328.43 | 323.88 | 308.24 | 288.92 | 212.16 |
Levered Free Cash Flow | 284.8 | 186.16 | 129.78 | 263.3 | 281.25 | 615.47 |
Unlevered Free Cash Flow | 290.14 | 190.77 | 140.32 | 270.61 | 287.63 | 619.83 |
Change in Working Capital | -147.61 | -147.61 | 128.91 | -251 | 78.63 | -115.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.